Stay updated on Amivantamab Combo Therapy Clinical Trial
Sign up to get notified when there's something new on the Amivantamab Combo Therapy Clinical Trial page.

Latest updates to the Amivantamab Combo Therapy Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedTwo new publications were added to the Publications section: 'Amivantamab-Chemotherapy in Non-Small Cell Lung Cancer with EGFR Exon 20 Insertions: Impact of Treatment Crossover and Other Endpoints from the Phase III PAPILLON Study' (Target Oncol. 2025) and 'Amivantamab Plus Chemotherapy in Japanese Patients With EGFR Exon 20 Insertions NSCLC' (Cancer Sci. 2025). The two earlier publications with the same titles were removed.SummaryDifference0.0%

- Check17 days agoChange DetectedRevision updated from v3.3.1 to v3.3.2 on the page.SummaryDifference0.0%

- Check24 days agoChange DetectedAdded note that PubMed publications are auto-filled and may not pertain to the study; Revision: v3.3.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check31 days agoChange DetectedNew date entries were added to the page (2025-11-13, 2026-09-30, 2025-11-06, 2025-11). Obsolete notices about funding lapses and earlier updates were removed.SummaryDifference0.2%

- Check38 days agoChange DetectedAdded a new publication reference under Publications: Amivantamab-Chemotherapy in NSCLC with EGFR Exon 20 Insertions: Impact of Treatment Crossover and Other Endpoints from the PAPILLON Study (Target Oncol, 2025).SummaryDifference0.0%

- Check45 days agoChange DetectedThe Study Details page now shows a new 'Last Update Posted (Estimated)' label in place of the previous 'Last Update Posted' timestamp.SummaryDifference0.2%

Stay in the know with updates to Amivantamab Combo Therapy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Amivantamab Combo Therapy Clinical Trial page.